Brian Maas, RPh Clinical Consultant

Drug Management

10 Most Expensive Drugs in the US

The Ultra Expensive Drugs. Who’s paying? With the entry of Zolgensma into the market in 2019, the prescription drug market changed almost instantly. T...

Read More
FDA Approvals | Healthcare | COVID-19 | Vaccine | Treatments

FDA Authorized Booster for People With Weakened Immune Systems

Estimate impact of high-risk COVID population Background As expected, on August 12, the U.S. Food and Drug Administration (FDA) authorized a booster d...

Read More
Treatments

Digital Therapeutics (DTx)

Digital Therapeutics (DTx) is somewhat of a new term in the healthcare realm, but this is one trend in the industry that is likely to stick around.

Read More
COVID-19 | Vaccine

COVID Vaccine Update: Understanding Immunity and Potential for Boosters

As of mid June, at least 173.8 million people have received one or both doses of a coronavirus vaccine in the U.S. This includes more than 143.9 milli...

Read More
COVID-19 | Vaccine

COVID Vaccine Update

With three COVID-19 vaccines approved under Emergency Use Authorization (EUA), what is the latest regarding additional vaccine approvals? Let us look ...

Read More
COVID-19 | Vaccine

The COVID Vaccine Derby: A Guide to the Top Contenders

The Race To A New Normal: A COVID-19 Vaccine Pipeline Update The medical community has been feverishly working toward a COVID-19 vaccine and we are no...

Read More